Guei-Sheung Rick Liu
I am a Senior Research Fellow and led a gene-based therapy research group at Menzies Institute for Medical Research, the University of Tasmania. I obtained my PhD at Kaohsiung Medical University (Taiwan) in 2006 and awarded a fellowship from “The Aim for the Top University Plan, Taiwan” for my postdoc training at National Cheng Kung University (2008-2009). Subsequently, I relocated to the O’Brien Institute (2009-2011) and then Centre for Eye Research Australia (Ophthalmology, University of Melbourne; 2012-2016) where I established gene therapy research. In 2017, I was recruited to the Menzies Institute for Medical Research to lead gene-based therapy research. My research has expanded from traditional “gene augmentation therapy” to emerging “gene editing” approaches. Recently, I helped lead the first application of viral-mediated CRISPR/Cas editing in the retina and a major focus of my ongoing work, will be to refine these applications thereby clearing the hurdles impeding clinical translation. I also serve on the editorial board of PLoS One and Journal of Gene Medicine, as well as undertake extensive peer review for over 30 international journals and national/international bodies for project and fellowship. I also hold an honorary appointment as a Principal Investigator at Jinan University (Ophthalmology) in China and Senior Fellow at University of Melbourne (Ophthalmology).